Pos F - Search Results

1

Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder.

Bex A, de Vries R, Pos F, Kerst M, Horenblas S. Bex A, et al. Among authors: pos f. World J Urol. 2009 Feb;27(1):101-6. doi: 10.1007/s00345-008-0304-x. Epub 2008 Jul 8. World J Urol. 2009. PMID: 18607595

2

Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients.

Jahreiß MC, Hoogeman M, Aben KK, Dirkx M, Snieders R, Pos FJ, Janssen T, Dekker A, Vanneste B, Minken A, Hoekstra C, Smeenk RJ, Incrocci L, Heemsbergen WD. Jahreiß MC, et al. Radiother Oncol. 2023 Jun;183:109659. doi: 10.1016/j.radonc.2023.109659. Epub 2023 Mar 30. Radiother Oncol. 2023. PMID: 37003369 Free article.

3

[Good results of bladder-preserving treatment in poorly differentiated and invasive bladder carcinoma using interstitial Iridium-192 radiotherapy].

Moonen LM, Horenblas S, Pos F, Schaefer BS, Meinhardt W, Bartelink H. Moonen LM, et al. Among authors: pos f. Ned Tijdschr Geneeskd. 1996 Jul 6;140(27):1406-10. Ned Tijdschr Geneeskd. 1996. PMID: 8766684 Dutch.

4

Concomitant boost radiotherapy for muscle invasive bladder cancer.

Pos FJ, van Tienhoven G, Hulshof MC, Koedooder K, González González D. Pos FJ, et al. Radiother Oncol. 2003 Jul;68(1):75-80. doi: 10.1016/s0167-8140(03)00019-7. Radiother Oncol. 2003. PMID: 12885455

5

Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.

Pos FJ, Horenblas S, Lebesque J, Moonen L, Schneider C, Sminia P, Bartelink H. Pos FJ, et al. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):696-705. doi: 10.1016/j.ijrobp.2003.11.040. Int J Radiat Oncol Biol Phys. 2004. PMID: 15183473

6

Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.

Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S. Bex A, et al. Among authors: pos f. Urology. 2005 Feb;65(2):295-9. doi: 10.1016/j.urology.2004.09.049. Urology. 2005. PMID: 15708041

7

Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?

Pos F, Horenblas S, Dom P, Moonen L, Bartelink H. Pos F, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):678-86. doi: 10.1016/j.ijrobp.2004.06.249. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708245

8

Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience.

Nieuwenhuijzen JA, Pos F, Moonen LM, Hart AA, Horenblas S. Nieuwenhuijzen JA, et al. Among authors: pos f. Eur Urol. 2005 Aug;48(2):239-45. doi: 10.1016/j.eururo.2005.03.022. Epub 2005 Apr 13. Eur Urol. 2005. PMID: 16005375

9

Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?

Pos FJ, Hart G, Schneider C, Sminia P. Pos FJ, et al. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1168-73. doi: 10.1016/j.ijrobp.2005.09.023. Epub 2006 Jan 10. Int J Radiat Oncol Biol Phys. 2006. PMID: 16376486

10

Tumor motion and deformation during external radiotherapy of bladder cancer.

Lotz HT, Pos FJ, Hulshof MC, van Herk M, Lebesque JV, Duppen JC, Remeijer P. Lotz HT, et al. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1551-8. doi: 10.1016/j.ijrobp.2005.12.025. Int J Radiat Oncol Biol Phys. 2006. PMID: 16580504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters